Category: COVID-19
Pfizer begins developing a vaccine that is effective against several omicron and the basic COVID virus.
According to Pfizer Inc.’s top executive, the company is working on a hybrid vaccine that combines its initial injection with a formulation that protects against the highly transmissible omicron version. While research continues, Pfizer will compare the new hybrid formulation to an omicron-specific injection to see which is better for moving ahead by March, according …